Translational examinations of the role of B-Lymphozyte stimulator (BLyS) in the pathophysiology of type 2 diabetes in humans

Recruiting

• Conditions: E11; E66.9; Type 2 diabetes mellitus; Obesity, unspecified

• Registration Number: DRKS00005070
• Lead Sponsor: KSH, Campus KielKlinik für Innere Medizin 1

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-06-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

1. obesity and/or type 2 diabetes
2. informed consent
3. men and women, 18-80 years of age
4. caucasian descent

Exclusion Criteria

1. lipodystrophy
2. oncological disease
3. LFT >3-fold of normal range
4. creatinin > 1.5 mg/dl
5. Hyper- or hypotcortisolism
6. Hyper- or hypothyreosis
7. known HIV, HBV oder HCV infektion

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in BLyS erum levels between day 0 and weeks 4 and 12.

Secondary Outcome Measures

Name	Time	Method
Changes in body weight between day 0 and weeks 4 and 12.